Efficacy, Safety, and Dose-Response Characteristics of Glipizide Gastrointestinal Therapeutic System on Glycemic Control and Insulin Secretion in NIDDM: Results of two multicenter, randomized, placebo-controlled clinical trials
Year: 1997
Type: article
Study design: Clinical Trial
Source: Diabetes Care
Authors: Donald C Simonson, Ione A Kourides, Mark Feinglos, Harry Shamoon, Christine T Fischette, The Glipizide Gastrointestinal Therapeutic System Study Group
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: glipizide, gastrointestinal therapeutic system, sustained-release formulation, type 2 diabetes, glycemic control, insulin secretion, C-peptide, dose-response relationship, HbA1c, fasting blood glucose, postprandial blood glucose, pharmacodynamics, pharmacokinetics, drug safety, adverse events, hypoglycemia, drug interactions
Open Access status: closed
OpenAlex ID: W2061936289
